Neuropace
NPCE
NPCE
90 hedge funds and large institutions have $294M invested in Neuropace in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
26% more capital invested
Capital invested by funds: $234M → $294M (+$60.6M)
3.59% more ownership
Funds ownership: 69.91% → 73.5% (+3.6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
90
Holding in Top 10
1
Calls
$22K
Puts
$5K
Top Buyers
| 1 | +$36.5M | |
| 2 | +$19.5M | |
| 3 | +$9.87M | |
| 4 |
AC
Armistice Capital
New York
|
+$6.89M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.29M |
Top Sellers
| 1 | -$59M | |
| 2 | -$6.55M | |
| 3 | -$4.6M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$3.07M |
| 5 |
Jane Street
New York
|
-$1.12M |